Meeting
2023 ASCO Gastrointestinal Cancers Symposium
Clinical therapeutic effects of neoadjuvant chemotherapy in resectable pancreatic cancer.
Authors
Masaaki Murakawa
Departments of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Japan;
Masaaki Murakawa , Daishi Takahashi , Shinnosuke Kawahara , Yuto Kamioka , Naoto Yamamoto , Shun Tezuka , Satoshi Kobayashi , Makoto Ueno , Manabu Morimoto , Takashi Oshima , Norio Yukawa , Yasushi Rino , Soichiro Morinaga
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer
Sub Track
Patient-Reported Outcomes and Real-World Evidence
Citation
J Clin Oncol 41, 2023 (suppl 4; abstr 677)
DOI
10.1200/JCO.2023.41.4_suppl.677
Abstract #
677
Poster Bd #
J2
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Impact of patient characteristics and treatment patterns on outcomes in potentially resectable pancreatic cancer (PC).
First Author: Andrew Steinmetz
Poster
2018 Gastrointestinal Cancers Symposium
Outcomes and characteristics of patients receiving second-line therapy for advanced pancreatic cancer.
First Author: Erica S Tsang
Poster
2017 Gastrointestinal Cancers Symposium
Clinical outcomes in borderline resectable pancreatic cancer: A cohort study.
First Author: Davendra Sohal
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Association of race and CA 19-9 nonproduction with limited pathologic response to neoadjuvant chemotherapy in patients with localized pancreatic cancer.
First Author: Mary P. Martos